5E Advanced Materials, Inc. FEAM said that it has completed a 20-ton commercial tank trial of its boric acid product with a major U.S.-based LCD glass manufacturer, marking a key milestone in its push toward full commercialization. The trial confirmed that 5E’s boric acid met all required specifications, including impurity levels, moisture content, particle size distribution, flowability and overall logistics performance, demonstrating its suitability for use in high-precision LCD glass applications.
This concludes a comprehensive qualification process that started in April 2025 with laboratory testing and advanced through a supply-chain trial completed in August. The successful commercial-scale run, initiated in December 2025, not only validates 5E’s capability to deliver consistent, on-spec product but also moves the company closer to securing an initial offtake agreement with the customer.
The company highlighted that the achievement represents another meaningful milestone on 5E’s path to commercialization, positioning the company with the necessary customer approvals as it works to become a reliable supplier of refined borates and advanced boron materials for fast-growing industrial sectors.
The announcement also follows boron’s recent addition to the U.S. Department of the Interior’s 2025 critical minerals list, underscoring the growing importance of establishing secure domestic supply chains.
Shares of FEAM are up 7.5% over the past six months against the industry’s 4.7% decline.
Image Source: Zacks Investment Research
FEAM’s Zacks Rank & Key Picks
FEAM currently carries a Zacks Rank of #4 (Sell).
Better-ranked stocks in the Basic Materials space include Flotek Industries, Inc. FTK, Novozymes A/S NVZMY and Commercial Metals Company CMC. FTK and CMC sport a Zacks Rank of #1 (Strong Buy), while NVZMY carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for FTK’s current-year earnings is pegged at $1.04 per share, indicating a 206% year-over-year increase. Its earnings beat the Zacks Consensus Estimates in all of the trailing four quarters, with the average earnings surprise of 70%.
The Zacks Consensus Estimate for NVZMY’s current fiscal-year earnings stands at $2.33 per share, reflecting a 24% year-over-year increase. Shares of NVZMY are down by 11.2% over the past six months.
The Zacks Consensus Estimate for CMC’s current fiscal-year earnings is pegged at $7.12 per share, indicating a 127.5% year-over-year increase. Shares of CMC are up by 35% over the past six months.
Free Report: Profiting from the 2nd Wave of AI Explosion
The next phase of the AI explosion is poised to create significant wealth for investors, especially those who get in early. It will add literally trillion of dollars to the economy and revolutionize nearly every part of our lives.
Investors who bought shares like Nvidia at the right time have had a shot at huge gains.
But the rocket ride in the "first wave" of AI stocks may soon come to an end. The sharp upward trajectory of these stocks will begin to level off, leaving exponential growth to a new wave of cutting-edge companies.
Zacks' AI Boom 2.0: The Second Wave report reveals 4 under-the-radar companies that may soon be shining stars of AI’s next leap forward.
Access AI Boom 2.0 now, absolutely free >>Commercial Metals Company (CMC) : Free Stock Analysis Report
Novozymes A/S (NVZMY) : Free Stock Analysis Report
Flotek Industries, Inc. (FTK) : Free Stock Analysis Report
5E Advanced Materials, Inc. (FEAM) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
